ACLS
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Richa, E.
Right arrow Articles by Stubbs, J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Richa, E.
Right arrow Articles by Stubbs, J.
Annals of Clinical & Laboratory Science 37:167-169 (2007)
© 2007 Association of Clinical Scientists


Brief Communication

Eluate Testing Following Microscopically Positive Direct Antiglobulin Tests with Anti-IgG

Elie Richa, Georgette Benidt, Craig Tauscher, Robert Stowers, Sandra Bryant and James Stubbs
Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, Minnesota

Address correspondence to Elie Richa, M.D., 200 1st Ave SW, Rochester, MN 55905, USA; tel 507 284 9010; fax 507 284 1339; e-mail: richa.elie{at}mayo.edu.

The direct antiglobulin test (DAT) demonstrates the presence of immunoglobulin (eg, IgG) or complement on the surface of red blood cells (RBCs). Immunoglobulin can be removed from RBCs by elution. The liquid end-product of elution procedures, the eluate, can be evaluated by antibody identification procedures. Antibody identification studies following acid/EDTA elution and DATs performed in our immunohematology laboratory during 2005 were evaluated to determine the usefulness of eluate testing following a microscopically positive IgG DAT. In total, 310 eluates were prepared during the year 2005; 146 of these eluates were derived from RBC samples with a microscopically positive DAT. The remaining eluates were derived from RBC samples with macroscopically positive IgG DATs (85 were weakly +; 32 were 1+; 40 were 2+; and 7 were 3+). Data were collected for the number and types of new antibodies (warm autoantibodies or alloantibodies) that were identified as a consequence of eluate testing. The incidence of new alloantibodies in the microscopically positive group (0.7%) was significantly lower than the combined incidence in the macroscopically positive groups (5.5%, p = 0.02). Based on these results, the authors conclude that performing antibody identification procedures on acid/EDTA eluates derived from RBC samples with microscopically positive IgG DATs has limited utility.

Keywords: blood transfusion, blood bank procedures, direct antiglobulin test, antibody identification







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2007 by the Association of Clinical Scientists.